Mirbeg-S 25 Tablet ER
Marketer
Ipca Laboratories Ltd
Salt Composition
Mirabegron (25mg) + Solifenacin (5mg)
Overview Mirbeg-S 25 Tablet ER
Combiflam-B 25mg Extended Release tablets combine two active ingredients to manage overactive bladder symptoms. This medication alleviates urinary frequency, urgency, and incontinence. Always follow your physician's instructions regarding dosage and treatment duration. It can be taken with or without food, ideally at the same time daily. Discontinue use only after consulting your doctor, as abrupt cessation may worsen symptoms. Complete the prescribed course for optimal results. Commonly reported side effects include elevated blood pressure, inflammation of the nose and throat, urinary tract infections, and headaches. Report any persistent or bothersome side effects promptly to your doctor. Before starting treatment, disclose all other medications and pre-existing conditions, including pregnancy or breastfeeding. Patients with liver or kidney impairment should exercise caution, requiring close monitoring by their healthcare provider.
Uses of Mirbeg-S 25 Tablet ER
Symptoms associated with an overactive bladder
Major Benefits of Mirbeg-S 25 Tablet ER:
Follow your doctor's instructions precisely regarding dosage and treatment length for Mirbeg-S 25 Tablet ER. Ingest the tablet whole; avoid chewing, crushing, or breaking it. While this extended-release tablet can be administered with or without food, consistent timing is recommended for optimal results.
Common Side effects of Mirbeg-S 25 Tablet ER:
- High blood pressure
- Nasopharyngitis (inflammation of the throat and nasal passages)
- Urinary tract infection
- Headache
- Dryness in mouth
- Constipation
- Increased heart rate
- Blurred vision
How to use Mirbeg-S 25 Tablet ER:
Follow your doctor's instructions precisely regarding the dosage and treatment length for Mirbeg-S 25 Tablet ER. Ingest the tablet whole; avoid chewing, crushing, or breaking it. While this medication can be administered with or without food, consistent timing is recommended for optimal results.
How Mirbeg-S 25 Tablet ER works:
Mirbeg-S 25 Extended-Release tablets contain Mirabegron and Solifenacin, two medications that synergistically manage bladder control. Mirabegron, a beta-3 adrenergic agonist, stimulates bladder receptors, promoting muscle relaxation. Solifenacin, an antimuscarinic agent, similarly eases bladder muscle contractions. This dual mechanism reduces the frequency, urgency, and incontinence associated with overactive bladder.
SAFETY ADVICE
AlcoholCAUTION
Exercise caution when drinking alcohol while taking Mirbeg-S 25 ER tablets. Seek medical advice.
PregnancyCONSULT YOUR DOCTOR
Data on Mirbeg-S 25 Tablet ER use in pregnancy is lacking. Seek medical advice from your physician.
Breast feedingCONSULT YOUR DOCTOR
Data on Mirbeg-S 25 Tablet ER use while breastfeeding is lacking. Seek medical advice from your physician.
DrivingCONSULT YOUR DOCTOR
Mirbeg-S 25 Tablet ER's effect on driving ability is undetermined. Refrain from driving if experiencing symptoms impairing concentration or reaction time.
KidneyCONSULT YOUR DOCTOR
Insufficient data exists regarding Mirbeg-S 25 Tablet ER use in individuals with renal impairment. Physician consultation is advised.
LiverCONSULT YOUR DOCTOR
Data regarding Mirbeg-S 25 Tablet ER use in individuals with hepatic impairment is scarce. Physician consultation is advised.
What if you forget to take Mirbeg-S 25 Tablet ER :
NA
Facts to Know About Mirbeg-S 25 Tablet ER
| Label | Value |
|---|---|
| Developing Habits | No. |
| Treatment Category | Urology |
3,018 People bought this recently